Navigation Links
NHP Reports Fourth Quarter and Full Year 2007 Earnings

1,845 100,340 77,714

Depreciation in income from

unconsolidated joint venture 668 --- 1,703 ---

Gains on sale of facilities (26,880) (79,283) (118,114) (96,791)

FFO available to common

stockholders 52,927 41,528 194,953 151,337

Series B preferred dividend add-

back 2,062 2,062 8,250 8,250

Diluted FFO 54,989 43,590 203,203 159,587

Impairments --- --- --- 83

Non-recurring settlement of

delinquent tenant obligations (1,667) --- (3,632) ---

Recurring diluted FFO $53,322 $43,590 $199,571 $159,670

Weighted average shares outstanding

for FFO

Diluted weighted average shares

outstanding 93,990 85,392 91,129 77,879

Series B preferred stock add-back 4,717 4,693 4,707 4,688

Fully diluted weighted average

shares outstanding 98,707 90,085 95,836 82,567

Diluted per share amounts:

FFO $0.56 $0.48 $2.12 $1.93

Recurring FFO $0.54 $0.48 $2.08 $1.93

Dividends declared per common share $0.41 $0.39 $1.64 $1.54

Recurring FFO payout ratio 76% 81% 79% 80%

Recurring FFO Coverage 1.32 1.23 1.27 1.25

Reconciliation of 2008 Net Income

Guidance to 2008 Diluted FFO and

Diluted FAD Guidance

Low High

Net income $1.21 $1.26

Real estate related

depreciation and amortization 1.21 1.21

Less: gains on sale (0.23)

SOURCE Nationwide Health Properties, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine news :

1. High Calcium Intake May Not Help Prevent Fractures, Reports The Harvard Health Letter
2. Clarity for Consumers on Botox Complication and Death Reports
3. Neurochem reports results for fourth quarter and fiscal year 2007 and important advances on corporate objectives
4. Emageon Reports Fourth Quarter and 2007 Financial Results
5. Cyberonics Reports Operating Profit for Third Quarter FY08 and Announces Share Repurchase Program
6. Platinum Underwriters Holdings, Ltd. Reports Record Fourth Quarter and Year Ended December 31, 2007 Financial Results
7. Onyx Pharmaceuticals Reports Fourth Quarter and Twelve-Month 2007 Financial Results
8. Cambrex Reports Fourth Quarter and Full-Year 2007 Results
9. Shengtai Pharmaceutical, Inc. Reports Strong Second Quarter Results of Fiscal Year 2008
10. TeamStaff Reports First Quarter Net Income and $0.7 Million Income Improvement From Continuing Operations Over Prior Year
11. The Quantum Group Reports 4th Quarter and Year End Results for Fiscal Year 2007
Post Your Comments:
(Date:7/9/2014)... More scientific research into the metabolism of stromal support ... the metabolism of these cell types in the development ... diabetes, inflammatory conditions and cancer. That was the conclusion ... KU Leuven in the leading journal Nature . ... sort of wake-up call. The metabolism of cancer cells ...
(Date:7/9/2014)... injection drug users in Russia might contribute to ... study, conducted by researchers from Boston University Schools ... St. Petersburg Pavlov State University, sought to discover ... outcomes of a cohort of HIV-positive people with ... were arrested by police were more likely to ...
(Date:7/9/2014)... release is available in French . ... in 14 year old teens, including brain structure and function, ... accuracy who will go on to develop binge drinking within ... conscientiousness, and other variables such as life events and a ... binge drinking. Whether or not the child had had ...
(Date:7/9/2014)... and extinctions around the world have been linked ... new research from the National Institute for Mathematical ... ranavirus, may also contribute. , In a ... which causes severe hemorrhage of internal organs in ... wood frogs if they are exposed to the ...
(Date:7/9/2014)... National Institute of Allergy and Infectious Diseases (NIAID), ... launched an early-stage clinical trial of CRS3123, an ... difficile ( C. difficile ) infection. CRS3123 ... that inhibits C. difficile growth while sparing normal ... enroll up to 30 healthy men and women ...
Breaking Medicine News(10 mins):Health News:Wake-up call for more research into cell metabolism 2Health News:BU researchers relate arrests with HIV risk environment 2Health News:What drives a child to abuse alcohol? 2Health News:Study predicts ranavirus as potential new culprit in amphibian extinctions 2Health News:NIH launches Phase I clinical trial of novel drug to treat Clostridium difficile infection 2
... among those who apply the chemicals, study shows , ... pesticides have double the normal risk of developing a ... (monoclonal gammopathy of undetermined significance) and characterized by an ... monitoring because it can lead to multiple myeloma, a ...
... of Facebook, Twitter coincides with 30% drop in hours spent ... American kids and their parents are now spending more hours ... eroding the amount of time families spend together. , That,s ... week that families interact as group has fallen by nearly ...
... Power Plate(R) North America (PPNA), the global ... trend in fitness and beauty to the greater Los ... studio opening this month for the summer in Brentwood, ... machines, "Power Plate(R) - The Experience" will provide group ...
... stay up at night worrying whether they are going to develop ... and middle age is a lifetime away. As ... Feinberg School of Medicine have found that young adults (18 to ... a treadmill test -- are two to three times more likely ...
... scientists are among a multinational collaborative group to have ... European Union. The research will focus on ... common to all solid tumours. Hypoxia causes a ... resistant to radiotherapy and most forms of chemotherapy; as ...
... June 18 George Dahlman, senior vice president of ... testified today before the U.S. Senate Subcommittee on Defense ... cancer research program at the Department of Defense (DoD). ... determined that several blood cancers, including chronic lymphocytic leukemia ...
Cached Medicine News:Health News:Pesticides Linked to Blood Disorder 2Health News:Surging Internet Use Cutting Into Family Time 2Health News:Surging Internet Use Cutting Into Family Time 3Health News:Power Plate(R) Opens Cutting-Edge Studio in L.A. 2Health News:Aerobically unfit young adults on road to diabetes in middle age 2Health News:$16.8 million study will breathe new life into cancer battle 2Health News:The Leukemia & Lymphoma Society Calls for Blood Cancer Research Program at the Department of Defense 2
(Date:1/15/2014)... Shire plc (LSE: SHP, NASDAQ: SHPG ) ... approval condition to the announced tender offer for all of the ... a result of the waiver, the transaction is no longer conditional ... on January 24, 2014 following the currently scheduled expiration time, subject ...
(Date:1/15/2014)... LOUISVILLE, Ky. , Jan. 15, 2014  Manufacturers, ... technologies must be able to protect their most ... (Logo: ) Because ... Industry, it steadfastly remains one of the most ...
(Date:1/15/2014)... , Jan. 15, 2014 MultiCell Technologies, Inc. ... a U.S. provisional patent application concerning composition of matter, ... achieve targeted tumor cell death.  This ... noncoding double stranded RNA molecules (VSRNAs) which interfere with ...
Breaking Medicine Technology:Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3Intellectual Property Insurance for Medical-related Products and Services 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3
The generously sized STERILE VIEW Monk Hood from DePuy provides splash protection in the chin and neck areas from body fluids and liquids. Shoulder cut outs and ties ensure a comfortable fit. This pr...
STERILE VIEW Barrier Sleeves combine superior protection against contaminants with unsurpassed comfort and the convenience of universal sizing....
... UltraFit PK System rede phines sharpness ... trephine program for penetrating keratoplasty. Advanced ... cutting edge to achieve the critical fit ... disposable and fully customized system enables surgeons ...
Digital Imaging for Optical Screening:,Diabetes, Glaucoma Macular Degeneration, and other retinal disease....
Medicine Products: